secwatch.observer — SEC 8-K summary
======================================

Issuer:     Annovis Bio, Inc. (ANVS)
CIK:        0001477845
Form:       8-K
Filed at:   2024-03-15T23:59:59+00:00
Accession:  0001104659-24-035082
Event type: other_material
Sentiment:  neutral
Materiality: 0.50
Item codes: 1.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Annovis Bio enters securities purchase agreement for $1.025M common stock offering
--------------------------------------------------------------------------------

- Sold 114,911 shares at $8.92/share to institutional investor for gross proceeds of $1,025,000.
- Issued under effective shelf registration statement on Form S-3 (333-276814) effective Feb 12, 2024.
- Closing expected promptly after conditions satisfied, including NYSE listing of the shares.
- 30-day lock-up restricts additional equity issuances, warrant amendments, and variable rate transactions.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1477845/000110465924035082/0001104659-24-035082-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1477845/000110465924035082/tm248952d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-24-035082

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer